Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I know it’s been asked before,

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Feb 21, 2024 1:46pm

181 Views

Post# 35891361

RE:RE:I know it’s been asked before,

If the plan is to get BTD in Q2, at least they should be close of sending the application in. Of course, schedules have a tendency to change, but perhaps the next update can shed some light about how things are going.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week